KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Return on Sales (2016 - 2025)

Globus Medical (GMED) has disclosed Return on Sales for 15 consecutive years, with 0.17% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 13.0% year-over-year to 0.17%, compared with a TTM value of 0.18% through Dec 2025, up 14.0%, and an annual FY2025 reading of 0.18%, up 14.0% over the prior year.
  • Return on Sales was 0.17% for Q4 2025 at Globus Medical, up from 0.15% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.27% in Q2 2025 and bottomed at 0.72% in Q4 2022.
  • Average Return on Sales over 5 years is 0.09%, with a median of 0.16% recorded in 2022.
  • The sharpest move saw Return on Sales plummeted -78bps in 2022, then soared 74bps in 2023.
  • Year by year, Return on Sales stood at 0.06% in 2021, then crashed by -1289bps to 0.72% in 2022, then surged by 103bps to 0.02% in 2023, then surged by 65bps to 0.04% in 2024, then skyrocketed by 322bps to 0.17% in 2025.
  • Business Quant data shows Return on Sales for GMED at 0.17% in Q4 2025, 0.15% in Q3 2025, and 0.27% in Q2 2025.